Abstract
An efficient fedbatch process for the production of Lactobacillus kefir DSM 20587 cells was developed. An improvement in space time yield of 270% (3.7 gDCW l−1 day−1) and in final enzyme activity of 440% (9.1 U/ml) was achieved on a 150 l scale by controlling the oxygen transfer rate to 7–9 mmol l−1 h−1. The cells exhibited good and highly stereoselective reducing activities against tert-butyl 6-chloro-3,5-dioxohexanoate. tert-Butyl (3R,5S)-6-chloro-dihydroxyhexanoate, a chiral building block for HMG-CoA reductase inhibitor synthesis, was produced with 47.5% yield and >99% ee at C33 and C55 in a simple batch biotransformation process.
References
Beck G, Jendralla H, Kesseler K (1995) Practical large scale synthesis of tert-butyl (3R,5S)-6-hydroxy-3,5-O-isopropylidene-3,5-dihydroxyhexanoate: essential building block for HMG-CoA reductase inhibitors. Synthesis 1014–1018
Faber K (1997) Biotransformations in organic chemistry: a textbook. Springer, Berlin Heidelberg New York
Haberland J, Kriegesmann A, Wolfram E, Hummel W, Liese A (2002) Diastereoselective synthesis of optically active (2R,5R)-hexanediol. Appl Microbiol Biotechnol 58:595–599
Hummel W (1990) Reduction of acetophenone to R(+)-phenylethanol by a new alcohol dehydrogenase from Lactobacillus kefir. Appl Microbiol Biotechnol 34:15–19
Kandler O, Kunath P (1983) Lactobacillus kefir sp.nov., a component of the microflora of kefir. Syst Appl Microbiol 4:286–294
Kataoka M, Yamamoto K, Kawabata H, Wada M, Kita K, Yanase H, Shimizu S (1999) Stereoselective reduction of ethyl 4-chloro-3-oxobutanoate by Escherichia coli transformant cells coexpressing the aldehyde reductase and glucose dehydrogenase genes. Appl Microbiol Biotechnol 51:486–490
Kizaki N, Yasohara Y, Hasegawa J, Wada M, Kataoka M, Shimizu S (2001) Synthesis of optically pure ethyl (S)-4-chloro-3-hydroxybutanoate by Escherichia coli transformant cells coexpressing the carbonyl reductase and glucose dehydrogenase genes. Appl Microbiol Biotechnol 55:590–595
Kroutil W, Mang H, Edegger K, Faber K (2004) Recent advances in the biocatalytic reduction of ketones and oxidation of sec-alcohols. Curr Opin Chem Biol 8:120–126
Matsuyama A, Yamamoto H, Kobayashi Y (2002) Practical application of recombinant whole-cell biocatalysts for the manufacturing of pharmaceutical intermediates such as chiral alcohols. Org Process Res Dev 6:558–561
Pfruender H, Amidjojo M, Kragl U, Weuster-Botz D (2004) Efficient whole-cell biotransformation in a biphasic ionic liquid/water system. Ang Chem Int Ed 43:4529–4531
Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts M, Witholt B (2001) Industrial biocatalysis today and tomorrow. Nature 409:258–268
Thottathil JK, Pendri Y, Li WS, Kronenthal DR (1994) Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors. US patent 5278313 (Chem Abstracts 1994:217700)
Wess G, Kesseler K, Baader E, Bartmann W, Beck G, Bergmann A, Jendralla H, Bock K, Holzstein G, Kleine H, Schnierer M (1990) Stereoselective synthesis of HR 780, a new highly potent HMG-CoA reductase inhibitor. Tetrahedron Lett 31:2545–2548
Wolberg M, Hummel W, Wandrey C, Muller M (2000) Highly regio- and enantioselective reduction of 3,5-dioxocarboxylates. Ang Chem Int Ed 39:4306–4308
Wolberg M, Hummel W, Muller M (2001) Biocatalytic reduction of beta, delta-diketo esters: a highly stereoselective approach to all four stereoisomers of a chlorinated beta, delta-dihydroxy hexanoate. Chem-Eur J 7:4562–4571
Acknowledgements
The authors are very grateful to M. Mueller for discussion and for providing us with the dioxohexanoate and hydroxyhexanoate products. We would like to thank W. Hummel and T. Daussmann (Juelich Fine Chemicals, Germany) for helpful discussions. This work was supported by the Deutsche Bundesstiftung Umwelt (grant no. AZ 13040/03)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pfruender, H., Amidjojo, M., Hang, F. et al. Production of Lactobacillus kefir cells for asymmetric synthesis of a 3,5-dihydroxycarboxylate. Appl Microbiol Biotechnol 67, 619–622 (2005). https://doi.org/10.1007/s00253-004-1837-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-004-1837-6